StockData
OPCHNasdaqServices-Home Health Care ServicesFiscal year ends December 31

Option Care Health, Inc.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on Jul 29, 2026
$31.21+0.01 (+0.03%)

Close on Oct 19, 2026

Market cap
$4.94B
P/E (TTM)
24.2
Dividend yield
–

About Option Care Health

Services-Home Health Care Services, SIC 8082

Option Care Health, Inc. provides home and alternate-site infusion therapy services across a single operating segment. Operating under physician direction, the company supplies pharmaceuticals, complex compounded sterile solutions, and clinical care coordination to patients suffering from complex acute and chronic conditions. Key therapy areas encompass anti-infectives, clinical nutrition support, immunoglobulin treatments, chronic inflammatory and neurological disorders, bleeding disorders, heart failure, and specialized women's health regimens. Option Care Health serves patients in home environments and ambulatory suites, while contracting directly with managed care organizations, commercial third-party payers, hospitals, healthcare providers, and pharmaceutical manufacturers.

The company operates a nationwide footprint comprising 196 locations across 43 U.S. states. This delivery network includes 87 full-service pharmacies—73 of which contain ambulatory infusion suites—alongside 109 stand-alone ambulatory infusion suites, including 27 equipped with advanced practitioner capabilities. Clinical operations are supported by more than 5,000 clinicians, including pharmacists, dietitians, and approximately 2,700 employed nurses. Corporate headquarters are located in Bannockburn, Illinois.

Summary of the business section of Option Care Health's latest annual report, written by StockData.

Company profile

Company

Legal name
Option Care Health, Inc.
Headquarters
Bannockburn, IL
Address
3000 Lakeside Dr, Suite 300n 60015
Phone
(312) 940-2443
Employees
2,700, Dec 31, 2025
Industry
Services-Home Health Care Services
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
KPMG LLP, Chicago, Illinois

Stock & identifiers

Ticker
OPCH
Exchange
Nasdaq
Shares outstanding
150M, Jul 27, 2026
Public float
$5.27B, Jun 30, 2025
Filer category
Large accelerated filer
Stock splits
1-for-4 reverse, Feb 3, 2020; 1-for-4 reverse, Feb 3, 2020; 9-for-2, Nov 6, 2019
SEC CIK
1014739
CUSIP
68404L201
ISIN
US68404L2016
LEI
549300DI3Q5ACSYJRI17
EIN
05-0489664

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
John Charles RademacherChief Executive Officer, Director695,152
Prateek BhatiaEVP Sp Sales & Solutions16,386
Collin SmyserGC & Corporate Secretary77,512
Meenal SethnaChief Financial Officer98,337
Femi AdewunmiChief Medical Officer25,314
Michael BavaroChief Human Resources Officer33,249
Luke WhitworthChief Operating Officer169,589
Nicole MaggioChief Accounting Officer28,489
Christopher L. GrashoffChief Growth Officer44,092
Michael H. ShapiroChief Financial Officer311,933
Timothy P. SullivanDirector82,380
Harry M. Jansen Kraemer JrDirector458,997
Norman L. WrightDirector24,498
Elizabeth D. BierbowerDirector32,871
R. Carter PateDirector20,620
Eric BrandtDirector19,356
Natasha DeckmannDirector32,002
Barbara W. BodemDirector21,087
David W. GoldingDirector116,525
Elizabeth Quadros BettenDirector29,216

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Mr.Rademacher
$9.27M$21.64M$2.63M$204$110
FY2024
Mr.Rademacher
$8.22M-$1.87M$2.79M$148$93
FY2023
Mr.Rademacher
$16.61M$22.23M$3.65M$215$92
FY2022
Mr.Rademacher
$6.75M$10.07M$1.94M$192$87
FY2021
Mr.Rademacher
$8.42M$13.14M$3.29M$182$109
FY2020
Mr.Rademacher
$1.14M$1.14M$1.12M$105$133

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“The Company also provides nursing services to support the above therapies, comprised of its nursing team of approximately 2,700 employees, and through its network of sub-contracted nursing agencies.”

Corporate history

Events identified from SEC filings

DateEventDetails
Jun 5, 2023MergerRegistration of securities for a merger or exchange offer (S-4)
Aug 13, 2019Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 7, 2019Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 2, 2019Name changeName changed from BioScrip, Inc. to Option Care Health, Inc.
Jun 26, 2019Merger voteDefinitive merger proxy statement
Mar 15, 2018Late filingNotification of late filing
Sep 12, 2016Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 12, 2016ListingRegistration of securities on an exchange (Form 8-A)
Aug 31, 2015Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 6, 2015MergerRegistration of securities for a merger or exchange offer (S-4)
Sep 8, 2014Auditor changeChange in certifying accountant (8-K Item 4.01)
Apr 1, 2014Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Aug 27, 2013Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 4, 2013Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
May 10, 2012Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jun 22, 2010MergerRegistration of securities for a merger or exchange offer (S-4)
Mar 31, 2010Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Feb 23, 2010Merger voteDefinitive merger proxy statement
Aug 14, 2008Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 25, 2008Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Oct 27, 2006Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jul 19, 2006Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jul 11, 2006Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jun 1, 2006Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 16, 2006Late filingNotification of late filing
Mar 2, 2006Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 1, 2006Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 17, 2005Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 14, 2005Name changeName changed from MIM CORP to BioScrip, Inc.
Sep 28, 2004Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)